-
1
-
-
79952232216
-
Global cancer statistics
-
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. (2011). Global cancer statistics. CA Cancer J Clin 61:69-90.
-
(2011)
CA Cancer J Clin
, vol.61
, pp. 69-90
-
-
Jemal, A.1
Bray, F.2
Center, M.M.3
Ferlay, J.4
Ward, E.5
Forman, D.6
-
2
-
-
0027972129
-
Prognostic factors in non-small cell lung cancer
-
Feld R, Borges M, Giner V, Ginsberg R, Harper P, Klastersky J, Lacquet L, Paesmans M, Payne D, Rosell R. (1994). Prognostic factors in non-small cell lung cancer. Lung Cancer 11 Suppl 3:S19-S23.
-
(1994)
Lung Cancer
, vol.11
, Issue.SUPPL. 3
-
-
Feld, R.1
Borges, M.2
Giner, V.3
Ginsberg, R.4
Harper, P.5
Klastersky, J.6
Lacquet, L.7
Paesmans, M.8
Payne, D.9
Rosell, R.10
-
3
-
-
0037312404
-
Pretreatment clinical prognostic factors in patients with stage IV non-small cell lung cancer (NSCLC) treated with chemotherapy
-
Jeremic B, Milicic B, Dagovic A, Aleksandrovic J, Nikolic N. (2003). Pretreatment clinical prognostic factors in patients with stage IV non-small cell lung cancer (NSCLC) treated with chemotherapy. J Cancer Res Clin Oncol 129:114-122.
-
(2003)
J Cancer Res Clin Oncol
, vol.129
, pp. 114-122
-
-
Jeremic, B.1
Milicic, B.2
Dagovic, A.3
Aleksandrovic, J.4
Nikolic, N.5
-
4
-
-
0034488459
-
Prognostic factors in advanced non-small cell lung cancer: Elevated serum levels of neuron specific enolase indicate poor prognosis
-
Maeda T, Ueoka H, Tabata M, Kiura K, Shibayama T, Gemba K, Takigawa N, Hiraki A, Katayama H, Harada M. (2000). Prognostic factors in advanced non-small cell lung cancer: Elevated serum levels of neuron specific enolase indicate poor prognosis. Jpn J Clin Oncol 30:534-541.
-
(2000)
Jpn J Clin Oncol
, vol.30
, pp. 534-541
-
-
Maeda, T.1
Ueoka, H.2
Tabata, M.3
Kiura, K.4
Shibayama, T.5
Gemba, K.6
Takigawa, N.7
Hiraki, A.8
Katayama, H.9
Harada, M.10
-
5
-
-
0033754806
-
Lung cancer proliferation correlates with [F-18] fluorodeoxyglucose uptake by positron emission tomography
-
Vesselle H, Schmidt RA, Pugsley JM, Li M, Kohlmyer SG, Vallires E, Wood DE. (2000). Lung cancer proliferation correlates with [F-18] fluorodeoxyglucose uptake by positron emission tomography. Clin Cancer Res 6:3837-3844.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 3837-3844
-
-
Vesselle, H.1
Schmidt, R.A.2
Pugsley, J.M.3
Li, M.4
Kohlmyer, S.G.5
Vallires, E.6
Wood, D.E.7
-
6
-
-
0028785953
-
Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography
-
Duhaylongsod FG, Lowe VJ, Patz EF Jr, Vaughn AL, Coleman RE, Wolfe WG. (1995). Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography. Ann Thorac Surg 60:1348-1352.
-
(1995)
Ann Thorac Surg
, vol.60
, pp. 1348-1352
-
-
Duhaylongsod, F.G.1
Lowe, V.J.2
Patz Jr., E.F.3
Vaughn, A.L.4
Coleman, R.E.5
Wolfe, W.G.6
-
7
-
-
0025765748
-
Cell cycle related studies on thymidine kinase and its isoenzymes in Ehrlich ascites tumours
-
He Q, Skog S, Tribukait B. (1991). Cell cycle related studies on thymidine kinase and its isoenzymes in Ehrlich ascites tumours. Cell Prolif 24:3-14.
-
(1991)
Cell Prolif
, vol.24
, pp. 3-14
-
-
He, Q.1
Skog, S.2
Tribukait, B.3
-
8
-
-
0026315964
-
Cell cycle regulation of thymidine kinase: Residues near the carboxyl terminus are essential for the specific degradation of the enzyme at mitosis
-
Kauffman MG, Kelly TJ. (1991). Cell cycle regulation of thymidine kinase: Residues near the carboxyl terminus are essential for the specific degradation of the enzyme at mitosis. Mol Cell Biol 11:2538-2546.
-
(1991)
Mol Cell Biol
, vol.11
, pp. 2538-2546
-
-
Kauffman, M.G.1
Kelly, T.J.2
-
9
-
-
0347986676
-
Mitotic degradation of human thymidine kinase 1 is dependent on the anaphase-promoting complex/cyclosome-CDH1-mediated pathway
-
Ke PY, Chang ZF. (2004). Mitotic degradation of human thymidine kinase 1 is dependent on the anaphase-promoting complex/cyclosome-CDH1-mediated pathway. Mol Cell Biol 24:514-526.
-
(2004)
Mol Cell Biol
, vol.24
, pp. 514-526
-
-
Ke, P.Y.1
Chang, Z.F.2
-
10
-
-
0029997983
-
Characterization of a peptide antibody against a C-terminal part of human and mouse cytosolic thymidine kinase, which is a marker for cell proliferation
-
He Q, Skog S, Wang N, Eriksson S, Tribukait B. (1996). Characterization of a peptide antibody against a C-terminal part of human and mouse cytosolic thymidine kinase, which is a marker for cell proliferation. Eur J Cell Biol 70:117-124.
-
(1996)
Eur J Cell Biol
, vol.70
, pp. 117-124
-
-
He, Q.1
Skog, S.2
Wang, N.3
Eriksson, S.4
Tribukait, B.5
-
11
-
-
77953698379
-
Thymidine kinase 1 is a potential marker for prognosis and monitoring the response to treatment of patients with breast, lung, and esophageal cancer and non-Hodgkin's lymphoma
-
He E, Xu XH, Guan H, Chen Y, Chen ZH, Pan ZL, Tang LL, Hu GZ, Li Y, Zhang M, Zhou J, Eriksson S, Fornander T, Skog S. (2010). Thymidine kinase 1 is a potential marker for prognosis and monitoring the response to treatment of patients with breast, lung, and esophageal cancer and non-Hodgkin's lymphoma. Nucleosides Nucleotides Nucleic Acids 29:352-358.
-
(2010)
Nucleosides Nucleotides Nucleic Acids
, vol.29
, pp. 352-358
-
-
He, E.1
Xu, X.H.2
Guan, H.3
Chen, Y.4
Chen, Z.H.5
Pan, Z.L.6
Tang, L.L.7
Hu, G.Z.8
Li, Y.9
Zhang, M.10
Zhou, J.11
Eriksson, S.12
Fornander, T.13
Skog, S.14
-
12
-
-
77955708527
-
Serum thymidine kinase 1 correlates to clinical stages and clinical reactions and monitors the outcome of therapy of 1,247 cancer patients in routine clinical settings
-
Chen Y, Ying M, Chen Y, Hu M, Lin Y, Chen D, Li X, Zhang M, Yun X, Zhou J, He E, Skog S. (2010). Serum thymidine kinase 1 correlates to clinical stages and clinical reactions and monitors the outcome of therapy of 1,247 cancer patients in routine clinical settings. Int J Clin Oncol 15:359-368.
-
(2010)
Int J Clin Oncol
, vol.15
, pp. 359-368
-
-
Chen, Y.1
Ying, M.2
Chen, Y.3
Hu, M.4
Lin, Y.5
Chen, D.6
Li, X.7
Zhang, M.8
Yun, X.9
Zhou, J.10
He, E.11
Skog, S.12
-
13
-
-
58149176415
-
The role of thymidine kinase in cancer diseases
-
Topolcan O, Holubec L. (2008). The role of thymidine kinase in cancer diseases. Expert Opin Med Diagn 2:129-141.
-
(2008)
Expert Opin Med Diagn
, vol.2
, pp. 129-141
-
-
Topolcan, O.1
Holubec, L.2
-
14
-
-
0020608312
-
The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma
-
Gronowitz JS, Hagberg H, Kallander CF, Simonsson B. (1983). The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma. Br J Cancer 47:487-495.
-
(1983)
Br J Cancer
, vol.47
, pp. 487-495
-
-
Gronowitz, J.S.1
Hagberg, H.2
Kallander, C.F.3
Simonsson, B.4
-
15
-
-
0023761315
-
Activity of serum thymidine kinase in non-Hodgkin lymphoma: Relationship to other prognostic factors
-
Hallek M, Emmerich B, Strohmeyer S, Busch R, Reichle A, Senekowitsch R. (1988). Activity of serum thymidine kinase in non-Hodgkin lymphoma: Relationship to other prognostic factors. Klin Wochenschr 66:718-723.
-
(1988)
Klin Wochenschr
, vol.66
, pp. 718-723
-
-
Hallek, M.1
Emmerich, B.2
Strohmeyer, S.3
Busch, R.4
Reichle, A.5
Senekowitsch, R.6
-
16
-
-
0029127269
-
Risk classification for large cell lymphoma using lactate dehydrogenase, beta-2 microglobulin, and thymidine kinase
-
Suki S, Swan F Jr, Tucker S, Fritsche HA, Redman JR, Rodriguez MA, McLaughlin P, Romaguera J, Hagemeister FB, Velasquez WS. (1995). Risk classification for large cell lymphoma using lactate dehydrogenase, beta-2 microglobulin, and thymidine kinase. Leuk Lymphoma 18:87-92.
-
(1995)
Leuk Lymphoma
, vol.18
, pp. 87-92
-
-
Suki, S.1
Swan Jr., F.2
Tucker, S.3
Fritsche, H.A.4
Redman, J.R.5
Rodriguez, M.A.6
McLaughlin, P.7
Romaguera, J.8
Hagemeister, F.B.9
Velasquez, W.S.10
-
17
-
-
0028905086
-
Prognostic value of cytosolic thymidine kinase activity as a marker of proliferation in breast cancer
-
Romain S, Christensen IJ, Chinot O, Balslev I, Rose C, Martin PM, Thorpe SM. (1995). Prognostic value of cytosolic thymidine kinase activity as a marker of proliferation in breast cancer. Int J Cancer 61:7-12.
-
(1995)
Int J Cancer
, vol.61
, pp. 7-12
-
-
Romain, S.1
Christensen, I.J.2
Chinot, O.3
Balslev, I.4
Rose, C.5
Martin, P.M.6
Thorpe, S.M.7
-
18
-
-
0035866373
-
Thymidine kinase and thymidylate synthase in advanced breast cancer: Response to tamoxifen and chemotherapy
-
Foekens JA, Romain S, Look MP, Martin PM, Klijn JG. (2001). Thymidine kinase and thymidylate synthase in advanced breast cancer: Response to tamoxifen and chemotherapy. Cancer Res 61:1421-1425.
-
(2001)
Cancer Res
, vol.61
, pp. 1421-1425
-
-
Foekens, J.A.1
Romain, S.2
Look, M.P.3
Martin, P.M.4
Klijn, J.G.5
-
19
-
-
33845963719
-
Thymidine kinase 1 in serum predicts increased risk of distant or loco-regional recurrence following surgery in patients with early breast cancer
-
He Q, Fornander T, Johansson H, Johansson U, Hu GZ, Rutqvist LE, Skog S. (2006). Thymidine kinase 1 in serum predicts increased risk of distant or loco-regional recurrence following surgery in patients with early breast cancer. Anticancer Res 26:4753-4759.
-
(2006)
Anticancer Res
, vol.26
, pp. 4753-4759
-
-
He, Q.1
Fornander, T.2
Johansson, H.3
Johansson, U.4
Hu, G.Z.5
Rutqvist, L.E.6
Skog, S.7
-
20
-
-
21244448424
-
Changes of thymidine kinase (TK) during adjuvant and palliative chemotherapy
-
Topolcan O, Holubec L Jr, Finek J, Stieber P, Holdenrieder S, Lamerz R, Holubec Sen L, Svobodova S, Visokai V, Lipska L. (2005). Changes of thymidine kinase (TK) during adjuvant and palliative chemotherapy. Anticancer Res 25:1831-1833.
-
(2005)
Anticancer Res
, vol.25
, pp. 1831-1833
-
-
Topolcan, O.1
Holubec Jr., L.2
Finek, J.3
Stieber, P.4
Holdenrieder, S.5
Lamerz, R.6
Holubec Sen, L.7
Svobodova, S.8
Visokai, V.9
Lipska, L.10
-
21
-
-
0021352005
-
Application of an in vitro assay for serum thymidine kinase: Results on viral disease and malignancies in humans
-
Gronowitz JK, llander C, Diderholm H, Hagberg H, Pettersson U. (1984). Application of an in vitro assay for serum thymidine kinase: Results on viral disease and malignancies in humans. Int J Cancer 33:5-12.
-
(1984)
Int J Cancer
, vol.33
, pp. 5-12
-
-
Gronowitz, J.K.1
Llander, C.2
Diderholm, H.3
Hagberg, H.4
Pettersson, U.5
-
22
-
-
77953765126
-
Transient increase in serum thymidine kinase 1 within one week after surgery of patients with carcinoma
-
Li Z, Wang Y, Ma J, He J, Zhou J, He E, Skog S. (2010). Transient increase in serum thymidine kinase 1 within one week after surgery of patients with carcinoma. Anticancer Res 30:1295-1299.
-
(2010)
Anticancer Res
, vol.30
, pp. 1295-1299
-
-
Li, Z.1
Wang, Y.2
Ma, J.3
He, J.4
Zhou, J.5
He, E.6
Skog, S.7
-
23
-
-
0025936268
-
Glucose uptake, perfusion, and cell proliferation in head and neck tumors: Relation of positron emission tomography to flow cytometry
-
Haberkorn U, Strauss LG, Reisser C, Haag D, Dimitrakopoulou A, Ziegler S, Oberdorfer F, Rudat V, van Kaick G. (1991). Glucose uptake, perfusion, and cell proliferation in head and neck tumors: Relation of positron emission tomography to flow cytometry. J Nucl Med 32:1548-1555.
-
(1991)
J Nucl Med
, vol.32
, pp. 1548-1555
-
-
Haberkorn, U.1
Strauss, L.G.2
Reisser, C.3
Haag, D.4
Dimitrakopoulou, A.5
Ziegler, S.6
Oberdorfer, F.7
Rudat, V.8
Van Kaick, G.9
-
24
-
-
0031593949
-
Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: A preliminary observation
-
Crippa F, Seregni E, Agresti R, Chiesa C, Pascali C, Bogni A, Decise D, De Sanctis V, Greco M, Daidone MG, Bombardieri E. (1998). Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: A preliminary observation. Eur J Nucl Med 25:1429-1434.
-
(1998)
Eur J Nucl Med
, vol.25
, pp. 1429-1434
-
-
Crippa, F.1
Seregni, E.2
Agresti, R.3
Chiesa, C.4
Pascali, C.5
Bogni, A.6
Decise, D.7
De Sanctis, V.8
Greco, M.9
Daidone, M.G.10
Bombardieri, E.11
-
25
-
-
28944441655
-
Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer
-
Hellwig D, Groschel A, Graeter TP, Hellwig AP, Nestle U, Schafers HJ, Sybrecht GW, Kirsch CM. (2006). Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer. Eur J Nucl Med Mol Imaging 33:13-21.
-
(2006)
Eur J Nucl Med Mol Imaging
, vol.33
, pp. 13-21
-
-
Hellwig, D.1
Groschel, A.2
Graeter, T.P.3
Hellwig, A.P.4
Nestle, U.5
Schafers, H.J.6
Sybrecht, G.W.7
Kirsch, C.M.8
-
26
-
-
0030946565
-
Prognostic value of histology in patients with non-small cell lung cancer
-
Charloux A, Hedelin G, Dietemann A, Ifoundza T, Roeslin N, Pauli G, Quoix E. (1997). Prognostic value of histology in patients with non-small cell lung cancer. Lung Cancer 17:123-134.
-
(1997)
Lung Cancer
, vol.17
, pp. 123-134
-
-
Charloux, A.1
Hedelin, G.2
Dietemann, A.3
Ifoundza, T.4
Roeslin, N.5
Pauli, G.6
Quoix, E.7
-
27
-
-
68549098156
-
The international association for the study of lung cancer staging project: Prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer
-
International Staging Committee Participating Institutions.
-
Chansky K, Sculier JP, Crowley JJ, Giroux D, Van Meerbeeck J, Goldstraw P; International Staging Committee and Participating Institutions. (2009). The International Association for the Study of Lung Cancer Staging Project: Prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer. J Thorac Oncol 4:792-801.
-
(2009)
J Thorac Oncol
, vol.4
, pp. 792-801
-
-
Chansky, K.1
Sculier, J.P.2
Crowley, J.J.3
Giroux, D.4
Van Meerbeeck, J.5
Goldstraw, P.6
|